TRANSLATIONAL RESEARCH IN CARDIOVASCULAR DISEASES: INNOVATIONS IN EARLY DETECTION AND TREATMENT APPROACHES

Abstract

Cardiovascular diseases (CVDs) remain the leading cause of global mortality, disproportionately affecting populations in low- and middle-income countries. The increasing burden is driven by aging demographics, sedentary lifestyles, and poor dietary habits, highlighting the urgent need for innovations in early detection and personalized treatment strategies. Translational research has emerged as a pivotal approach to bridging the gap between laboratory discoveries and clinical application, aiming to improve both diagnostic precision and therapeutic efficacy.This study integrates biomarker profiling, advanced imaging modalities, and artificial intelligence (AI)-based diagnostic models to enhance early detection capabilities. The methodology involves evaluating genetic and molecular indicators, applying machine learning algorithms for predictive risk stratification, and validating therapeutic innovations such as stem cell therapy and gene-targeted interventions.Results demonstrate that AI-enabled imaging models significantly outperform traditional methods in diagnostic sensitivity, while personalized pharmacogenomic approaches yield superior treatment outcomes with reduced adverse effects. Additionally, stem cell therapies show promising regenerative effects in myocardial repair, and gene editing technologies highlight future potential in correcting inherited cardiovascular disorders.In conclusion, the convergence of translational research, intelligent diagnostic systems, and targeted therapies represents a transformative shift in the management of CVDs. These innovations not only improve early intervention and clinical decision-making but also pave the way for precision medicine in cardiovascular healthcare. However, continued interdisciplinary collaboration and equitable deployment of these technologies are essential to maximize their global impact.